Strata Critical Medical, Inc. (SRTA) research
Strata Critical Medical, Inc.- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Last price
- $5.27
- As of
Strata Critical Medical, Inc. (SRTA): 3 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 10-Q filed 2026-08-04.
As of . Source: SEC EDGAR filings for SRTA. Method and limitations.
Share the SRTA intelligence card
See SRTA live in the terminal
Track SRTA's insider trades, 13F flows, options positioning, and cross asset confluence as they update, on one live board. Free account.
Open the live SRTA terminal, freeActive signals for SRTA
- highINSTITUTIONAL_SURGE
CITADEL ADVISORS LLC added +334% to SRTA (2026Q2)
- highINSTITUTIONAL_SURGE
CITADEL ADVISORS LLC added +215% to SRTA (2026Q2)
- highINSTITUTIONAL_SURGE
CITADEL ADVISORS LLC added +334% to SRTA (2026Q2)
- highINSTITUTIONAL_SURGE
CITADEL ADVISORS LLC added +215% to SRTA (2026Q2)
- highINSTITUTIONAL_SURGE
CITADEL ADVISORS LLC added +334% to SRTA (2026Q2)
FREE, NO ACCOUNT
Every signal on SRTA, as it fires
You are seeing 5 of 11 signals recorded on SRTA since 2026-05-29.
The five above landed across 2 days. The other 6 were recorded on 2 other days. 6 of the 11 are institutional flow rows, which arrive in batches on filing days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in SRTA (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| Third Point LLCCUSIP 092667104 · 2026Q2 | $26.4M | 0.56% | , |
| RENAISSANCE TECHNOLOGIES LLCCUSIP 092667104 · 2026Q2 | $2.6M | 0.00% | , |
| Point72 Asset Management, L.P.CUSIP 092667104 · 2026Q2 | $492K | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, SRTA
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
SRTA against its peers
SRTA's operating margin of -11.3% ranks in the 9th percentile of 16 Medical Care Facilities sub-industry peers, fiscal periods ending between 2025-12-31 and 2026-06-30.
| Metric | SRTA | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 197M USD | 1.4B USD | 18 | 18 |
| Gross margin | 20.9% | n/a | n/a | 4 |
| Operating margin | -11.3% | 2.1% | 9 | 16 |
| Net margin | 21.0% | 0.7% | 97 | 18 |
| Return on equity | 14.8% | 2.9% | 72 | 15 |
| P / E | 10.5x | 26.6x | 15 | 9 |
Peers (18): MCTA, TOI, CYH, AIRS, NUTX, ARDT, INNV, AGL, SGRY, JYNT, ASTH, SNDA, ADUS, GRDN, NHC, CON, LFST, DCGO. Left out: AUNA (no annual filing), GMRS (no annual filing), LTGHY (no annual filing), HWAIF (no annual filing), WW (no annual filing), PARK (no annual filing), BUHPY (no annual filing). Fiscal periods ending between 2025-12-31 and 2026-06-30. Every figure is one full fiscal year read from one annual filing (SRTA: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
See more SRTA signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to SRTAand get the insider, 13F, options, and confluence read in one view.